Multiple Assemblies exist for SMTL entry 6fmk
pVHL:EloB:EloC in complex with N-((S)-1-((2S,4R)-4-hydroxy-2-((4-(4-methylthiazol-5-yl)benzyl)carbamothioyl) pyrrolidin-1-yl)-1-thioxopropan-2-yl)acetamide (ligand 4); X-RAY DIFFRACTION 2.75 Å

SMTL ID
6fmk.1
Ligands
~{N}-[(2~{S})-1-[(2~{S},4~{R})-2-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methylcarbamothioyl]-4-oxidanyl-pyrrolidin-1-yl]-1-sulfanylidene-propan-2-yl]ethanamide
Polypeptides
Elongin-B; Elongin-C; von Hippel-Lindau disease tumor suppressor
Oligo-state
hetero-1-1-1-mer
SMTL ID
6fmk.2
Ligands
~{N}-[(2~{S})-1-[(2~{S},4~{R})-2-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methylcarbamothioyl]-4-oxidanyl-pyrrolidin-1-yl]-1-sulfanylidene-propan-2-yl]ethanamide
Polypeptides
Elongin-B; Elongin-C; von Hippel-Lindau disease tumor suppressor
Oligo-state
hetero-1-1-1-mer
SMTL ID
6fmk.3
Ligands
~{N}-[(2~{S})-1-[(2~{S},4~{R})-2-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methylcarbamothioyl]-4-oxidanyl-pyrrolidin-1-yl]-1-sulfanylidene-propan-2-yl]ethanamide
Polypeptides
Elongin-B; Elongin-C; von Hippel-Lindau disease tumor suppressor
Oligo-state
hetero-1-1-1-mer
SMTL ID
6fmk.4
Ligands
~{N}-[(2~{S})-1-[(2~{S},4~{R})-2-[[4-(4-methyl-1,3-thiazol-5-yl)phenyl]methylcarbamothioyl]-4-oxidanyl-pyrrolidin-1-yl]-1-sulfanylidene-propan-2-yl]ethanamide
Polypeptides
Elongin-B; Elongin-C; von Hippel-Lindau disease tumor suppressor
Oligo-state
hetero-1-1-1-mer